Comparing Dapagliflozin vs Semaglutide
| Dapagliflozin | Semaglutide |
|
|---|
| Dapagliflozin | Semaglutide |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Heart Failure, Chronic Kidney Disease, Type 2 Diabetes. Dapagliflozin may also be used for purposes not listed in this medication guide. |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Related suggestions Chronic Kidney Disease
Popular comparisons
|
|||||||
| More about Dapagliflozin | More about Semaglutide | ||||||||
| Ratings & Reviews | |||||||||
|
Dapagliflozin has an average rating of 4.7 out of 10 from a total of 195 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 46% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2621 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Dapagliflozin side effects |
View all Semaglutide side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Dapagliflozin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Farxiga | Ozempic, Rybelsus, Wegovy | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
12.9 hours |
168 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 372 drugs are known to interact with Dapagliflozin:
|
A total of 273 drugs are known to interact with Semaglutide:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 08, 2014 |
December 05, 2017 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Entresto
Entresto is an oral combination heart medication that contains two blood pressure-lowering ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.